Clinical Trial Update: Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer

View source ↗

Summary

Clinical trial update describing a study that uses whole exome sequencing to identify causative germline variants in patients with peripheral neuropathy who are…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Peripheral Neuropathy

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Carcinoma, Neuropathy | Status: RECRUITING